KYCID Omeprazole 40MG Injection is administered intravenously for the treatment of peptic ulcer disease, GERD, and Zollinger-Ellison syndrome. It belongs to drug class of proton pump inhibitors that are known to work by binding to H+/K+ ATPase pump and inhibiting final step of gastric acid production. This injection gets quickly absorbed to stomach's parietal cells for exerting curative effects. It shows bioavailability range of 35 to 76% and has protein binding ability of 95%. KYCID Omeprazole 40MG Injection gets metabolized in liver with the help of CYP2C19 & CYP3A4 and shows elimination half life of 1 to 1.2 hours.